EBM Conference- Paediatric cancer care: Changing paradigms in the 21st century

Download video

EBM Conference- Paediatric cancer care: Changing paradigms in the 21st century

28 views

Tata Memorial Centre

1 month ago

EBM Conference- Paediatric cancer care: Changing paradigms in the 21st century

4:07

BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC

by ecancer

22:48

GU Cancer ESMO 2025 Highlights: PSMAddition, Capitello-281, Potomac, Keynote-905, IMVigor011

by OncBrothers: Practice-Changing Cancer Discussions

56:54

Clinical Use of Blood Biomarkers in the Era of Disease Modifying Treatments

by C2N Diagnostics

58:36

HER2-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series

by Dana-Farber Cancer Institute

$Metastatic HR+\/HER2- Breast Cancer Case | CDK4\/6 Inhibitors, CNS Progression \& Treatment Strategies$

58:03

Metastatic HR+\/HER2- Breast Cancer Case | CDK4\/6 Inhibitors, CNS Progression \& Treatment Strategies

by American Board Certified Doctors for Egypt

1:16:24

EMN Webinar 20250325 - March 25, 2025

by Metabolomics Society

$Bioinformatic Analysis for Cancer Genomics 2025 22\/06\/2025$

2:22:18

Bioinformatic Analysis for Cancer Genomics 2025 22\/06\/2025

by Advanced VnPathoinformatics

5:22

ER+ metastatic breast cancer: Highlights from the 13th APBCS Satellite Symposium

by COR2ED The Heart of Medical Education

$Phase 2 Study of Anitocabtagene Autoleucel for Relapsed\/Refractory Multiple Myeloma: iMMagine-1$

11:17

Phase 2 Study of Anitocabtagene Autoleucel for Relapsed\/Refractory Multiple Myeloma: iMMagine-1

by International Myeloma Foundation

3:57

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared...

by ecancer

8:34

Things You Need to Know About ZEGFROVY for Lung Cancer Treatment

by Diseases and Medicines

$Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la\/mUC$

6:16

Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la\/mUC

by ecancer

$Encorafenib\/binimetinib\/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases$

3:46

Encorafenib\/binimetinib\/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases

by ecancer

$Endocrine Therapies in ER-Positive\/HER2-Negative MBC: Understanding Their Benefits and Limitation...$

31:51

Endocrine Therapies in ER-Positive\/HER2-Negative MBC: Understanding Their Benefits and Limitation...

by Medscape

$OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1\/2 metastatic ccRCC$

4:48

OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1\/2 metastatic ccRCC

by VJOncology

1:43

Aberrant RBMX Expression Relevant for Cancer Prognosis and Immunotherapy Response | Aging-US

by Aging-US

0:55

Mevrometostat and enzalutamide in mCRPC: gene expression and EZH2 modulation

by VJOncology

$Episode 2 - Conversations in Relapsed\/Refractory Multiple Myeloma$

18:18

Episode 2 - Conversations in Relapsed\/Refractory Multiple Myeloma

by Practice Point Communications

1:08:55

HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selection and Sequencing

by PeerView Oncology

5:16

Highlights: ER+ mBC: Key insights from the latest EMERALD subgroup analyses

by COR2ED The Heart of Medical Education

4:51

Promising Results from iMMagine-1 Anito-Cel Study | Gurbakhash Kaur, MD | EHA 2025 #myeloma

by HealthTree University for Multiple Myeloma

4:52

Breast cancer highlights from ESMO 2025

by COR2ED The Heart of Medical Education

Best on Vidoe

EBM Conference- Paediatric cancer care: Changing paradigms in the 21st century